Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
larger decrease » marked decrease (Expand Search)
decrease rice » decreased since (Expand Search), decrease i (Expand Search)
Showing 21 - 40 results of 13,546 for search '(( significantly ((larger decrease) OR (reported decrease)) ) OR ( significant decrease rice ))', query time: 2.46s Refine Results
  1. 21
    Significant relationships between QOL measures on infusion day and day 7.

    Significant relationships between QOL measures on infusion day and day 7. by Jordan K. Abbott (8934239)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 22
    Words for describing activities that decrease and/or increase Subjective Well-Being.

    Words for describing activities that decrease and/or increase Subjective Well-Being. by August Håkan Nilsson (12937056)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 23
    Pulsed-pedestal task video demonstrates a trial in the pulsed-pedestal paradigm.

    Pulsed-pedestal task video demonstrates a trial in the pulsed-pedestal paradigm. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 24
    An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedestal paradigm (MC pathway) flicker adaptation condition (filled circle); (3) pulsed-pedestal paradigm (PC pathway) non-flicker adaptation condition (open triangle); (4) pulsed-pedestal paradigm (PC pathway) flicker adaptation condition (filled triangle).

    An observer’s steady- and pulsed-pedestal threshold data and model fits: (1) steady-pedestal paradigm (MC pathway) non-flicker adaptation condition (open circle); (2) steady-pedest... by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 25
    Descriptive statistics for the free parameters.

    Descriptive statistics for the free parameters. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 26
    Fig 1 -

    Fig 1 - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 27
    Steady-pedestal task video demonstrates a trial in the steady-pedestal paradigm.

    Steady-pedestal task video demonstrates a trial in the steady-pedestal paradigm. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 28
    S1 Data -

    S1 Data - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 29
    Fig 3 -

    Fig 3 - by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 30
    Averaged contrast sensitivity parameter data (Mean and SD) for the MC and PC pathways by age group.

    Averaged contrast sensitivity parameter data (Mean and SD) for the MC and PC pathways by age group. by Xiaohua Zhuang (11890694)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 31
    OsNF-YAs disturb the transcriptional activation of OsMYC2/3.

    OsNF-YAs disturb the transcriptional activation of OsMYC2/3. by Xiaoxiang Tan (12542842)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 32
    Phase 2 significant effects.

    Phase 2 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  13. 33
    Phase 1 significant effects.

    Phase 1 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  14. 34
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 35
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 36
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 37
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 38
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 39
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: